Transparency begins …. with a T, as Ali G once said. That seems to be extent of the University of Liverpool’s commitment to openness, at least in the handling of an ongoing misconduct investigation at the UK institution.
We know this much: The school in late 2017 launched an inquiry into one of its scientists — apparently someone involved in liver research. The investigators concluded that the employee, who has since left the institution, had indeed committed research misconduct, according to a statement from the university.
The problem is, that’s all we know at this point. The university is refusing to name the researcher, identify any affected papers or shed any other light on the matter. The only salient facts in the statement are that the work involves:
Two years ago, I uploaded a preprint to arXiv.org describing what I considered serious problems, including apparently irreproducible results, that I had uncovered when analyzing a set of research articles published by the NASA Jet Propulsion Laboratory (JPL) NEOWISE project. NEOWISE is the largest scientific analysis of asteroids ever conducted; the researchers on the project have so far published estimated sizes of more than 164,000 objects in the solar system, estimates they have claimed were all derived by applying a standard approach to raw observations from the WISE space telescope.
The New England Journal of Medicine has retracted a 2013 paper that provided some proof that the Mediterranean diet can directly prevent heart attacks, stroke, and other cardiovascular problems.
Dismissing concerns of the Committee on Publication Ethics and extensive allegations of misconduct, a journal has corrected, but is refusing to retract, a 2016 paper linking online pornography to sexual dysfunction in men. The article, “Is internet pornography causing sexual dysfunctions? A review with clinical reports,” appeared last year in Behavioral Sciences, which is published by MDPI. After publication, critics asked COPE to look at the paper, and in particular whether the authors had obtained adequate informed consent for two patients described in the work. COPE, which has no enforcement authority, said in an email to the publisher that it would have recommended retraction of the article.
If you’ve been pausing at some detailed PLOS ONE notices lately — such as one issued last month for a cancer paper that lists 21 shortcomings — you’re not alone.
According to a spokesperson for the publisher, the journal has been progressively pushing towards more transparency in its notices — in part, because it was getting too many calls from our reporters, asking about details that weren’t in the notice but that were “easily answerable.” This isn’t the first time we’ve seen a journal become more transparent following these kinds of questions — the Journal of Biological Chemistry, for instance, has become much more informative in its retraction notice, following criticism for its previous opacity.
Both the spokesperson and editor Joerg Heber, who took the role in November 2016, were quick to clarify that the increase in detail of notices is not only due to our queries — instead, it’s meant to benefit the entire scientific community. According to the spokesperson: